Table 2.

Gastrointestinal symptoms among study subjects

	All Patients (136) n (%)	Patients with positive nasopharyngeal swab SARS-CoV-2 (120) n (%)	Patients with positive anal swab SARS-CoV-2 (45) n (%)
Gastrointestinal symptoms, n (%)	92 (67.6)	81 (67.5)	33 (73.3)
Anorexia Bloated stomach Diarrhoea Constipation Nausea Vomiting Abdominal pain	63 (46.3) 26 (19.1) 17 (12.5) 4 (2.9) 64 (47) 21 (15.4) 28 (20.6)	56 (46.7) 24 (20) 15 (12.5) 3 (2.5) 58 (48.3) 19 (15.8) 25 (20.8)	24 (53.3) 11 (24.4) 8 (17.8) 0 (0) 25 (55.6) 8 (17.8) 9 (20)